Cleavage of ST6Gal I by Radiation-Induced BACE1 Inhibits Golgi-Anchored ST6Gal I-Mediated Sialylation of Integrin β1 and Migration in Colon Cancer Cells

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Lee, Minyoung ^a   Park, Jung Jin ^a,b   Ko, Young Gyu ^b   Lee, Yun Sil ^c  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

BACE1; Migration; Radiation; ST6Gal i

Indexed keywords

BETA GALACTOSIDE ALPHA 2,6 SIALYLTRANSFERASE; BETA SECRETASE 1; BETA1 INTEGRIN; SIALYLTRANSFERASE; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BETA D GALACTOSIDE ALPHA 2 6 SIALYLTRANSFERASE; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; N ACETYLNEURAMINIC ACID; SECRETASE;

ARTICLE; ASSAY; CANCER CELL; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IONIZING RADIATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; CELL MOTION; COLON TUMOR; IMMUNOPRECIPITATION; METABOLISM; RADIATION EXPOSURE; TUMOR CELL LINE;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD29; ASPARTIC ACID ENDOPEPTIDASES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GOLGI APPARATUS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; N-ACETYLNEURAMINIC ACID; RADIATION, IONIZING; SIALYLTRANSFERASES;

EID: 84862792177     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-47     Document Type: Article

References (41)

1. Dall'Olio F. The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj J 2000, 17:669-676. 10.1023/A:1011077000164, 11425186.
2. Dall'Olio F, Chiricolo M, Ceccarelli C, Minni F, Marrano D, Santini D. Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int J Cancer 2000, 88:58-65. 10.1002/1097-0215(20001001)88:1<58::AID-IJC9>3.0.CO;2-Q, 10962440.
3. Lammers G, Jamieson JC. The role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6-sialyltransferase from rat liver Golgi membranes during the acute-phase response. The Biochemical journal 1988, 256:623-631. 1135455, 3146977.
4. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 2005, 65:4645-4652. 10.1158/0008-5472.CAN-04-3117, 15930282.
5. Le Marer N, Stehelin D. High alpha-2,6-sialylation of N-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential. Glycobiology 1995, 5:219-226. 10.1093/glycob/5.2.219, 7780196.
6. Lise M, Belluco C, Perera SP, Patel R, Thomas P, Ganguly A. Clinical correlations of alpha2,6-sialyltransferase expression in colorectal cancer patients. Hybridoma 2000, 19:281-286. 10.1089/027245700429828, 11001400.
7. Poon TC, Chiu CH, Lai PB, Mok TS, Zee B, Chan AT, Sung JJ, Johnson PJ. Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. World J Gastroenterol 2005, 11:6701-6706.
8. Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, Lai CR, Hsieh SL, Yuan CC. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecologic oncology 2005, 99:631-639. 10.1016/j.ygyno.2005.07.016, 16112178.
9. Stewart JF, Rubens RD, Hoare S, Bulbrook RD, Kessel D. Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapy. British journal of cancer 1982, 46:208-212. 10.1038/bjc.1982.185, 2011080, 6758827.
10. Bernacki RJ, Kim U. Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors. Science (New York, N.Y 1977, 195:577-580.
11. Gessner P, Riedl S, Quentmaier A, Kemmner W. Enhanced activity of CMP-neuAc: Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer letters 1993, 75:143-149. 10.1016/0304-3835(93)90056-F, 8313349.
12. Ganzinger U, Moser K. Sialyl transferase activity: a serum enzyme marker in the follow-up of cancer patients. Recent results in cancer research. Fortschritte der Krebsforschung 1979, 67:50-55.
13. Herrmann WP, Gielen W. Sialyltransferase levels and sialic acid concentrations in sera of patients with malignant melanomas. Archives of dermatological research 1979, 265:321-329. 10.1007/BF00412390, 475455.
14. Kawaguchi T. Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:39-64. 10.2174/1568006053005038, 15720223.
15. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer research 1996, 56:5309-5318.
16. Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer science 2008, 99:1304-1310. 10.1111/j.1349-7006.2008.00839.x, 18492092.
17. Gorelik E, Galili U, Raz A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 2001, 20:245-277. 10.1023/A:1015535427597, 12085965.
18. Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, Bellis SL. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem 2002, 277:32830-32836. 10.1074/jbc.M202493200, 12091385.
19. Seales EC, Jurado GA, Singhal A, Bellis SL. Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin. Oncogene 2003, 22:7137-7145. 10.1038/sj.onc.1206834, 14562042.
20. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001, 305:285-298. 10.1007/s004410100417, 11572082.
21. Van Slambrouck S, Grijelmo C, De Wever O, Bruyneel E, Emami S, Gespach C, Steelant WF. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. Int J Oncol 2007, 31:1501-1508.
22. Lee M, Park JJ, Lee YS. Adhesion of ST6Gal I-mediated human colon cancer cells to fibronectin contributes to cell survival by integrin beta1-mediated paxillin and AKT activation. Oncol Rep 2010, 23:757-761.
23. Lee M, Lee HJ, Bae S, Lee YS. Protein sialylation by sialyltransferase involves radiation resistance. Mol Cancer Res 2008, 6:1316-1325. 10.1158/1541-7786.MCR-07-2209, 18708363.
24. Lee M, Lee HJ, Seo WD, Park KH, Lee YS. Sialylation of integrin beta1 is involved in radiation-induced adhesion and migration in human colon cancer cells. Int J Radiat Oncol Biol Phys 2010, 76:1528-1536. 10.1016/j.ijrobp.2009.11.022, 20338479.
25. Jang ER, Ryu M, Park JE, Kim JH, Lee JS, Song K. A new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway. J Biol Chem 2010, 285:2986-2995. 10.1074/jbc.M109.070466, 2823446, 19948725.
26. Lee M, Lee HJ, Seo WD, Park KH, Lee YS. Sialylation of integrin beta1 is involved in radiation-induced adhesion and migration in human colon cancer cells. Int J Radiat Oncol Biol Phys 2010, 76:1528-1536. 10.1016/j.ijrobp.2009.11.022, 20338479.
27. Vassar R, Kovacs DM, Yan R, Wong PC. The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 2009, 29:12787-12794. 10.1523/JNEUROSCI.3657-09.2009, 2879048, 19828790.
28. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (New York, N.Y 1999, 286:735-741.
29. Kitazume S, Oka R, Ogawa K, Futakawa S, Hagiwara Y, Takikawa H, Kato M, Kasahara A, Miyoshi E, Taniguchi N, Hashimoto Y. Molecular insights into beta-galactoside alpha2,6-sialyltransferase secretion in vivo. Glycobiology 2009, 19:479-487. 10.1093/glycob/cwp003, 19150807.
30. Strous GJ. Golgi and secreted galactosyltransferase. CRC critical reviews in biochemistry 1986, 21:119-151. 10.3109/10409238609113610, 3093147.
31. Paone JF, Waalkes TP, Baker RR, Shaper JH. Serum UDP-galactosyl transferase as a potential biomarker for breast carcinoma. Journal of surgical oncology 1980, 15:59-66. 10.1002/jso.2930150110, 6775160.
32. De AK, Hardy RE. Elucidation of sialyltransferase as a tumour marker. Indian journal of biochemistry & biophysics 1990, 27:452-455.
33. Futakawa S, Kitazume S, Oka R, Ogawa K, Hagiwara Y, Kinoshita A, Miyashita K, Hashimoto Y. Development of sandwich enzyme-linked immunosorbent assay systems for plasma beta-galactoside alpha2,6-sialyltransferase, a possible hepatic disease biomarker. Analytica chimica acta 2009, 631:116-120. 10.1016/j.aca.2008.10.028, 19046688.
34. Kitazume S, Suzuki M, Saido TC, Hashimoto Y. Involvement of proteases in glycosyltransferase secretion: Alzheimer's beta-secretase-dependent cleavage and a following processing by an aminopeptidase. Glycoconjugate journal 2004, 21:25-29.
35. Sugimoto I, Futakawa S, Oka R, Ogawa K, Marth JD, Miyoshi E, Taniguchi N, Hashimoto Y, Kitazume S. Beta-galactoside alpha2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for alpha2,6-sialylation. The Journal of biological chemistry 2007, 282:34896-34903. 10.1074/jbc.M704766200, 17897958.
36. Lee HW, Seo HS, Ha I, Chung SH. Overexpression of BACE1 stimulates spontaneous basal secretion in PC12 cells. Neuroscience letters 2007, 421:178-183. 10.1016/j.neulet.2007.01.082, 17566645.
37. Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM, Orevi M. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstetrics and gynecology 1978, 52:321-327.
38. Seales EC, Shaikh FM, Woodard-Grice AV, Aggarwal P, McBrayer AC, Hennessy KM, Bellis SL. A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation. J Biol Chem 2005, 280:37610-37615. 10.1074/jbc.M508476200, 16157583.
39. Cordes N, Blaese MA, Meineke V, Van Beuningen D. Ionizing radiation induces up-regulation of functional beta1-integrin in human lung tumour cell lines in vitro. Int J Radiat Biol 2002, 78:347-357. 10.1080/09553000110117340, 12020426.
40. Cordes N, Park CC. beta1 integrin as a molecular therapeutic target. Int J Radiat Biol 2007, 83:753-760. 10.1080/09553000701639694, 18058364.
41. Cordes N, Seidler J, Durzok R, Geinitz H, Brakebusch C. beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 2006, 25:1378-1390. 10.1038/sj.onc.1209164, 16247454.